2021
DOI: 10.1111/bph.15617
|View full text |Cite
|
Sign up to set email alerts
|

Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review

Abstract: Existing pharmacotherapies for managing craving, a strong predictor of relapse to automated addictive behaviours, are limited in efficacy and characterised by increased health risks associated with their pharmacological profile. Preclinical studies have identified oxytocin as a promising pharmacotherapy with anticraving properties for addictive behaviours. Here, we provide the first systematic review of 17 human studies (n = 722; 30% female) investigating the efficacy of intranasal oxytocin to reduce craving o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 112 publications
0
6
0
Order By: Relevance
“…These views have gained supports from animal studies. IAO can decrease craving and relapse related to alcohol, cannabis, opioids, cocaine, or nicotine, etc ( Houghton et al, 2021 ; Van Hedger et al, 2020 ). Activation of OTRs during recovery from opioid overdose could also eliminate or attenuate negative side effects associated with traditional opioid receptor antagonism ( Brackley & Toney, 2021 ).…”
Section: Higher Brain Functionsmentioning
confidence: 99%
“…These views have gained supports from animal studies. IAO can decrease craving and relapse related to alcohol, cannabis, opioids, cocaine, or nicotine, etc ( Houghton et al, 2021 ; Van Hedger et al, 2020 ). Activation of OTRs during recovery from opioid overdose could also eliminate or attenuate negative side effects associated with traditional opioid receptor antagonism ( Brackley & Toney, 2021 ).…”
Section: Higher Brain Functionsmentioning
confidence: 99%
“…Given oxytocin’s putative ability to heighten the salience of social signals 29 33 , we reasoned that oxytocin might effectively address this symptom and improve social perception for methamphetamine users. Two, although we do not investigate these outcomes in this paper, oxytocin has demonstrated anti-addiction properties within humans for several other substances 34 and has been shown to attenuate seeking and self-administration of methamphetamine within animal models 35 41 . Thus, we reasoned that oxytocin may also show anti-addiction properties for methamphetamine use in humans as well.…”
Section: Introductionmentioning
confidence: 96%
“…This indicates that while periods of restricted use might require active levels of inhibition to prevent a return to social media before the intended end of the detox period, craving is unlikely to play an insurmountable role in maintaining periods of abstinence. However, for those individuals in which craving might be a barrier to SOCIAL MEDIA DETOX 22 maintaining a significant detox period, and we report that SMAQ scores are a good predictor of such individual differences, researchers should look to develop ways to reduce these urges (see Houghton et al, 2021 for a recent review on the benefits of intranasal oxytocin in this respect).…”
Section: Discussionmentioning
confidence: 96%